Joslin Diabetes Center is running a small trial to pilot test a mobile health app and an online nutrition education platform for people with Type 1 diabetes, according to a ClinicalTrials.gov posting.

Boston-based Joslin Diabetes Center has created a new non-profit division, called Joslin Institute for Technology Translation (JITT), so that the healthcare organization can collaborate with companies ...

BOSTON -- Joslin Diabetes Center has launched a new affiliation program designed to bring Joslin's world-class vision resources to local communities across the United States and beyond. The first ...

BOSTON--(BUSINESS WIRE)--Today, Peter S. Amenta, MD, PhD, announced that he will step down as President and CEO of Joslin Diabetes Center at the end of 2019. After that, he will remain an advisor to ...

Joslin Diabetes Center will take part in two clinical trials this year to test artificial pancreas systems designed to automatically monitor and regulate blood glucose levels in people with type 1 ...

Researchers and clinicians at Joslin Diabetes Center have established a Center for Cell-Based Therapy for Diabetes (CCTD), the goal of which is to lead the development and translation of cell-based ...

BOSTON -- Joslin Diabetes Center announced today that Ulrich H. von Andrian, M.D., Ph.D, is the first scientist to receive the new Mary K. Iacocca Faculty Fellowship at Joslin Diabetes Center. Dr. von ...

BOSTON--(BUSINESS WIRE)--BPGbio, a pioneering biology-first, AI-powered, clinical-stage biopharma specializing in mitochondrial biology and protein homeostasis, and Joslin Diabetes Center, the world's ...

Boston-based Beth Israel Lahey Health and Joslin Diabetes Center have signed a letter of intent for Joslin to join the BILH network. With the acquisition, the diabetes research, education and clinical ...

Joslin Diabetes Center will virtually host their annual Taste of Ginger event on May 16 and will honor Carol and Jeffrey Horvitz, of Beverly Farms. The couple’s connection to the art world sparked a ...